George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
And if you had read my previous posts ( On Lords Group) you would have also seen that I am a genuine Investor in this company, having invested very shortly after the IPO. I have also met the CEO, albeit some years before flotation BUT that was what gave me the confidence to invest when they came to the Market.
I will apologise for my comment about Ramping and withdraw, I accept you are a very committed Investor in Lords Group and I do respect your enthusiasm.
My initial comment about and reference to fundamentals purely meant there is absolutely nothing wrong with this company, exactly the opposite is the case. I thought my comment might create a more meaningful discussion, I'm sorry that isn't the case.
Share price still in a decline with little respite. I do think an update from the Company would be beneficial, even just to reassure Investors.
My own belief is that external Market dynamics are affecting sentiment, rather than any fundamentals associated with Lords Group. To date they have demonstrated their success in both organic and acquisition growth, albeit in their last report they reference the slowdown in the UK Building and Construction sector.
And there is the issue; Lords Group has a very wide portfolio of different businesses and products, so largely not reliant on just one segment / niche of the Building Industry. Yet Market Sentiment ( and the MM's) appears to adopt a disproportinately negative view and that's reflected in current Share Price.
I'm still a firm supporter of the company, would like to think it can recover to the Analyst's Projections of 100p + soon; I think thats unlikely until the second half of 2024 but I'm sticking with it.
The Share pattern and price is a difficult one to explain, and yes currently frustrating.
One could argue that in hindsight perhaps the flotation price was slightly on the high side, it enabled existing shareholders to benefit from flotation, but that’s normal and nothing unusual. Part of the re-distribution and expansion of the shareholder base post-flotation.
Is this a business sector that’s hard for investors to understand? Er, no. It probably one of the easiest, retailing and distribution of building and plumbing materials for both diy and small / medium sized contractors.
Some have mentioned the impact of Staff incentive Share plans, but from my experience that can only be a good thing.
Growth strategy -Solid and proven. Acquisition of similar, smaller family owned merchants looking to exit, plus emphasis on organise growth as well.
Profitable, even at this relatively early plc stage, paying a modest dividend.
My rationale for investment was very simple, I met the current CEO in a very minor business capacity, probably some 12 years ago and was very impressed with both him and the company. When I saw in the business press that they were coming to the market, to me it was a totally logical, nailed on investment.
Although I’m carrying a paper loss on this currently, my sentiment hasn’t changed, I like the company and genuinely believe it will be ultimately a very beneficial investment. As always, DYOR of course.
This is a frustrating investment currently. The recent results were by any parameters good, yet even allowing for the recent general market volatility, the share price has been hammered.
Pharma shares on AIM are notoriously volatile yet this isn’t a company trying to bring a drug through development or trial, their effective ‘support’ facilities to that sector are in high demand.
Future Order / Work pipeline is a big number, No debt, Cash still strong ( reduction on previous year easily explained by the Adamas acquisition).
EPS only marginally increased, perhaps the MM’s and Analysts were disappointed with that figure but that seems unlikely.
I’m nursing a bigger paper loss on this investment that I would normally tolerate, but like fellow commentators I still see this as an excellent medium term growth stock. Just currently frustrating, so guess go with the proverbial ups and downs of investing.
Yes, very solid figures. Share price today doesn't reflect that but a potential buying opportunity for those like myself who see this as a strong long term portfolio hold.
I believe their organic and acquisition growth strategy will continue, they could be a potential acquisition target themselves at some future date, although I personally don’t see that as a short / medium term possibility. IMHO
Note the comment
“It will be particularly welcome news for Synairgen’s embattled investors, who were tapped for £6.35m to fund further research in May this year. Shares, which have been as high as £1.60 each in January 2005 before plummeting to just 16p“
Plus ca change…..
Jimmy, the last thing I wanted to indicate was any aspect of showing off, and the last thing I am is a day or weekly trader, I’ve held investments for years in some instances. I also outlined that some shares I had invested in last year I thought had genuine prospects, I didn’t trade them and they turned out to be false.
I do believe your investment will ultimately have the return you wish for.
Yes off topic but goodness so relevant. You are right with good P3 results Synairgen would be largely immune to that market turbulence but a well respected German analyst has in the last few days assessed that the contagion and fall out from an Evergrande collapse could eclipse the 2008 Financial Crash.
One Analysts view admittedly but a definite concern that can’t be ignored.
As my posting history indicates, not a regular poster and 1st time on Synairgen, although I’ve followed the board since early 2020. I’ve been an active investor since 1985, like many long term investors had significant wins as well as losses. I’ve had recent AIM ‘significant disappointments’ , ODX, ABDX, HEMO ( ouch!) but Synairgen I genuinely believe is in a totally different league.
My investment in Synairgen ( or rather, ours) came from my wife seeing it tipped early 2020 and the fact that it was attractive not just from potential investment growth but also from the science and the potential that it offered to provide a realistic treatment.
Have I consistently held that initial investment? No, bought at circa 70p+, disappointed when it dropped to 40p until that magic Monday.
Bought more on the way up, sold out at 220p.
The profit was nice, not by any means the significant amounts fellow investors have committed but still nice.
Then what? Bought back in, within 2 weeks, because unlike other AIM so called ‘Covid’ stocks ( and I know Synairgen is much more than that ) I genuinely believe in the quality of management, the science and the belief that this treatment will achieve great things.
I know there is the possibility ( I do think small) that P3 might not go the way we all want, and whilst could cope with what would be a significant drop in value, I obviously wouldn’t wish that. That said, I’m solid with this and happy to wait for what will hopefully be successful and transformational results.
Interesting pattern in dealings , not I know the reason. Steady decline from the highs, seems like a determined regular seller in chunks of 3,000 a time.
Frustrating as I still personally think this is a good long term prospect.
Good point, one can only assume investors feeling stock oversold in the last week or so and buying back in. Accepting its an AIM stock and the volatility that can be associated with such, the movements do seem slightly odd with as you say no apparent news.
Volume today is much higher than recent days.
Think margins achievable on medium term basis, with the projected growth.
Achieving T/o projections will be dependent on more significant acquisitions rather than just existing organic growth, I believe this is probably part of their strategy.
There are a number of significant regional players with T/o between £50m -£100m, would think these are the prospects the board would have in their sight for an agreed takeover and integration.
I like the institutional backing and who they are I:e; Miton, Schroder plus strong family shareholding continuing post - IPO.
Have followed the origins of this company prior to the IPO for some years. Building Materials sector not necessarily the most exciting and some of the publicly listed ones still below their pre-pandemic listings.
That said, I think Lords should benefit in two ways, 1). Acquisition growth, from smaller family run merchants looking to exit the market
2). Increased economies of scale with reduced operating costs as company grows
They are operating in a competitive sector, larger internationally owned competitors will pose a threat but then some of those have their own challenges with a much larger location base and not all of those locations profitable.
One to perhaps lock away for 3yrs+ IMHO